Artificial Intelligence
World-first generative AI-based solution set to transform invention
New generation of Iprova’s invention platform will make inventing quicker, easier and more efficient. ...
Dr Cathy Tralau-Stewart appointed Executive Director of the Milner Therapeutics Institute
The Milner Therapeutics Institute are delighted to welcome Dr Cathy Tralau-Stewart as our new Executive Director. ...
Cambridge AI Club - April Theme - "Large language models for biomedical data"
The AI Club is a new initiative to bring together the Biomedical AI and Machine Learning community in Cambridge, to discuss common themes and explore different topics and methodologies. ...
Webinar: Integrated prediction of phase I and II metabolism
Want to avoid late-stage failure of your drug candidates? Understanding the metabolism of your compounds is crucial. On 24 May, join Optibrium CEO Matt Segall and Principal Scientist Mario Öeren to explore groundbreaking new quantum mechanics and machine learning models which...
AI is being exploited to create more convincing scams
Artificial Intelligence is all over the news. It seems like every time you go online, there’s more information about how it will either enhance or detract from our lives. However, as with everything, it’s not just being used for good. There’s no doubt it can and will change the way we ...
PRO Organises Roundtable With George Freeman, Science & Innovation Minister
The PR Office was joined by George Freeman MP, the Minister for Science, Research, Technology & Innovation at the newly created Department for Science, Innovation and Technology to talk to some of the most innovative and exciting companies in the world. Today, the Minister heard ...
Dr Hamed Tabatabaei Ghomi welcomed as Head of Research
Optibrium Appoints Computational Modelling Expert, Dr Hamed Tabatabaei Ghomi as Head of Research. ...
Bold Steps: Fireside chat with Dr Saleyha Ahsan
Join us for for this FREE event - a fireside chat with Dr Saleyha Ahsan, and hear how she carved out a tremendous career, starting in STEMM ...
Integrated AI Synthesis Prediction in Drug Discovery
We are delighted to join forces with PostEra to discuss how AI, machine learning and other computational tools can support the drug discovery process, by bringing you feasible synthetic routes to your target compounds. Join us 13 April 16:00 BST| 11:00 EDT| 8:00 PDT to:...
Optibrium and PostEra collaborate to integrate AI drug discovery solutions
The collaboration connects PostEra’s synthesis prediction technology with Optibrium’s comprehensive platform for design, optimisation and data analysis for small molecule discovery ...